A new class of drugs that 'silence’ disease-causing mechanisms of hitherto unaddressed disease conditions are set to mark the next wave in medicine. Major pharma companies have already dropped their hats into what is called RNAi (RNA interference) based drugs that can switch off defective mechanisms leading to a host of disorders.
Discuss   Add this link to...  Tell a friend   Bury

Comments Who Voted Related Links